PRAME promotes epithelial-to-mesenchymal transition in triple negative breast cancer
<p>The triple negative breast cancer (TNBC) paradox marks a major challenge in the treatment-decision making process. TNBC patients generally respond better to neoadjuvant chemotherapy compared to other breast cancer patients; however, they have a substantial higher risk of disease recurrence....
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | , , , , |
| Published: |
2019
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|